Cargando…

Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy

This study aimed to identify the utility of diffusion-weighted magnetic resonance (MR) imaging with an apparent diffusion coefficient (ADC) map as a predictor of the response of hepatocellular carcinoma (HCC) to cisplatin-based hepatic arterial infusion chemotherapy (HAIC). We retrospectively evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Pil Soo, Choi, Moon Hyung, Yang, Hyun, Lee, Soon Kyu, Chun, Ho Jong, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew, Choi, Joon-Il, Lee, Young Joon, Bae, Si Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711158/ https://www.ncbi.nlm.nih.gov/pubmed/33330098 http://dx.doi.org/10.3389/fonc.2020.600233

Ejemplares similares

Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis
por: Lee, Sung Won, et al.
Publicado: (2017)

Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
por: Lee, Jaejun, et al.
Publicado: (2021)

A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
por: Kim, Hee Yeon, et al.
Publicado: (2010)

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020)

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
por: Lee, Soon Kyu, et al.
Publicado: (2021)

An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2023)

Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
por: Kim, Ji Hoon, et al.
Publicado: (2023)

Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2012)

Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
por: Sung, Pil Soo, et al.
Publicado: (2020)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Rapidly Progressing Budd-Chiari Syndrome Complicated by Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2003)

Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin
por: Yoo, Sun Hong, et al.
Publicado: (2020)

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
por: Yang, Hyun, et al.
Publicado: (2017)

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with my- eloproliferative neoplasms
por: Lee, Jaejun, et al.
Publicado: (2020)

Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy
por: Lee, Hae Lim, et al.
Publicado: (2017)

Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2022)

Successful Treatment of Stereotactic Body Radiation Therapy Combined with Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Biliary Obstruction
por: Park, Chan-Kwon, et al.
Publicado: (2011)

MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
por: Park, Na Ri, et al.
Publicado: (2022)

Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
por: Joo, Yu Young, et al.
Publicado: (2019)

Long-Term Survival in a Patient With Ruptured Hepatocellular Carcinoma
por: Kim, Joon Sung, et al.
Publicado: (2009)

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

Manual versus automated image fusion of real-time ultrasonography and MR/CT images for radiofrequency ablation of hepatic tumors: results of a randomized prospective trial (NCT02705118)
por: Choi, Moon Hyung, et al.
Publicado: (2021)

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
por: Kwon, Jung Hyun, et al.
Publicado: (2010)

Application of Helical Tomotherapy for Two Cases of Advanced Hepatocellular Carcinoma
por: Kim, Joon Sung, et al.
Publicado: (2011)

Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
por: Lee, Ahlim, et al.
Publicado: (2022)

Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma
por: Woo, Hyun Young, et al.
Publicado: (2011)

Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus
por: Lee, Hae Lim, et al.
Publicado: (2021)

Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases
por: Jang, Bohyun, et al.
Publicado: (2016)

Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial
por: Lee, Soon Kyu, et al.
Publicado: (2023)

A Case of Hepatocellular Carcinoma with Pulmonary Metastases Treated Successfully with a Combination of Repeated Hepatic Arterial Infusion Epirubicin and Cisplatin Chemotherapy and Systemic Low-Dose Infusion of 5-Fluorouracil
por: Oh, Yun-Jung, et al.
Publicado: (2009)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
por: Sung, Pil Soo, et al.
Publicado: (2018)

Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma
por: Kim, Joon Goon, et al.
Publicado: (2020)

Clinical Outcomes of Delayed Clearance of Serum HBsAg in Patients with Chronic HBV Infection
por: Nam, Soon Woo, et al.
Publicado: (2007)

Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2023)

Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
por: Lee, Yong Seong, et al.
Publicado: (2023)

Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
por: Lee, Sung Won, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o7g5nv1oqnpqefc9lcjjqtt7rk